Sign In
Buy CSTL
$24.69
-0.795 (-3.12%)
At Close: Jul 24, 2026
Castle announced the publication of a systematic review and meta-analysis in JAAD.
Castle Posts Results of Collaborative Ocular Oncology Group Survey on the Management of Ocular Oncology Patients During the COVID-19 Pandemic.
Castle Announces Publication of Fourth Study Demonstrating Significant Impact of DecisionDx-UM on Treatment Plan Recommendations.
Head to Head Analysis: Castle Biosciences (NASDAQ:CSTL) and Guardant Health (NASDAQ:GH)
05:06am, Sunday, 22'nd Mar 2020
Castle Biosciences (NASDAQ:CSTL) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their divid
Critical Contrast: Castle Biosciences (NASDAQ:CSTL) versus Guardant Health (NASDAQ:GH)
07:02am, Friday, 20'th Mar 2020
Castle Biosciences (NASDAQ:CSTL) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their insti
Castle Biosciences Announces Fourth Quarter and Full-Year 2019 Results
08:05pm, Tuesday, 10'th Mar 2020
Castle announced its financial results for the fourth quarter and twelve months ended December 31, 2019.
Castle Biosciences Inc to Host Earnings Call
06:30pm, Tuesday, 10'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 10, 2020 / Castle Biosciences Inc (NASDAQ:CSTL) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 10, 2020 at 4
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
01:05pm, Thursday, 05'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) * 89bio Inc (NASDAQ: ETNB) * Arcus Biosciences In
Castle Biosciences Announces Issuance of First U.S. Patent Covering DecisionDx-Melanoma
12:00pm, Thursday, 05'th Mar 2020
Castle was issued its first U.S. patent related to DecisionDx-Melanoma.
Netflix And Dow Heavyweights Into The Earnings Confessional
01:23pm, Saturday, 18'th Jan 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Houston-area biotech co. to hire, double office space after $73.6M IPO
07:34pm, Tuesday, 14'th Jan 2020
Friendswood-based Castle Biosciences Inc. (Nasdaq: CSTL) has growth in mind after closing a multimillion-dollar initial public offering in 2019. Derek Maetzold, founder, president and CEO of Castle B
Does Castle Biosciences (NASDAQ:CSTL) Have A Healthy Balance Sheet?
11:46am, Tuesday, 24'th Dec 2019
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
We reveal 4 reasons your sun cream might not be working, causing you to burn
04:22pm, Friday, 23'rd Jun 2017
IT’S summer in Britain and with the heatwave comes the inevitable rainbow of sunburn. With health bods ramming home the importance of sun cream there really is no excuse. Or is there? We all …
Skin Analytics Seeks Funds on Crowdcube to Battle Melanoma Using Smartphone App & Attachable Camera
04:33pm, Thursday, 15'th Oct 2015
Hoping to put an end to mortality rate for Melanoma, Skin Analytics has launched an equity crowdfunding campaign on Crowdcube to raise £450,000 for its new ear
